Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Nanotechnology Programs at FDA

Nanotechnology Programs at FDA

                        Nanotechnology Guidance Documents
          Nanotechnology Task Force Home
          Science & Research
          Science and Research Special Topics
          Nanotechnology Programs at FDA
          2013 Nanotechnology Regulatory Science Research PlanNanotechnology Programs at FDA 2013 Nanotechnology Regulatory Science Research Plan
  
  	
    Share
    Post
    Linkedin

    Email
    PrintContents
**Goal**
    **Framework**
    **Implementation Strategy**
    **Outcomes****FDA Nanotechnology Regulatory Science Research Plan—Goal**
*What is FDA’s Plan for Nanotechnology Regulatory Science Research?*
The FDA Nanotechnology Regulatory Science Research Plan lays out a framework and implementation plan to provide coordinated leadership on regulatory science activities and issues related to FDA-regulated products that either contain nanomaterial or otherwise involve the application of nanotechnology.  The goal of providing coordinated leadership of FDA’s regulatory science research helps to address key scientific gaps in knowledge, methods, or tools needed to make regulatory assessments of these products.
*Why does FDA have a Nanotechnology Regulatory Science Research Program?*
FDA is developing a regulatory science program in nanotechnology to foster the responsible development of FDA-regulated products that may contain nanomaterials or otherwise involve the application of nanotechnology.  The program establishes the tools, methods, and data to assist in regulatory decision-making, while also providing in-house scientific expertise and capacity that is responsive to nanotechnology-related FDA-regulated products.
FDA defines Regulatory Science as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.  FDA has recently published a Strategic Plan for Regulatory Science that identifies eight priority topics for the Agency to focus in the coming years.  A critical area identified in the FDA plan is to “Ensure FDA Readiness to Evaluate Innovative Emerging Technology”, and nanotechnology is a part of the strategic plan.
*Who is leading this effort?*
The FDA Nanotechnology Task Force, with representatives from across the Agency, will facilitate communication on nanotechnology regulatory science both within FDA and with national and international stakeholders, and provide overall coordination of FDA’s nanotechnology regulatory science research efforts.
**The FDA Nanotechnology Regulatory Science Research Plan—Framework**
The Program contains four areas:
**Staff Training and Professional Development**Staff training and professional development to strengthen the nanotechnology-specific scientific expertise within the agency.
    **Laboratory Core Facilities**Laboratory Core Facilities to support regulatory science.
    **Collaborative Opportunities for Research Excellence in Science (CORES) Program******Collaborative Opportunities for Research Excellence in Science (CORES) Program to promote cross-center and external collaborative research opportunities for identified high priority FDA regulatory science nanotechnology research needs, reflecting the National Nanotechnology Initiative Environmental, Health, and Safety Research Strategy (see Table 1: NNI EHS Research Needs Cross Walk to FDA Regulatory Science Research Categories).**Table 1:****NNI EHS Research Needs Cross Walk to FDA Regulatory Science Research Categories**
NNI EHS Research Needs
            FDA Regulatory Science Research Categories
            FDA Research GoalsDevelop measurement tools for determination of physico-chemical properties of Engineered Nanomaterials (ENMs) in relevant media.
            Physico-chemical Characterization
            Develop improved methods and tools to detect and measure the physical structure, chemical properties, and safety of nanomaterials in FDA-regulated products:
            In biological matrices, to assess the impact of biological systems on physical structure, chemical properties, and safety; and
                To be used by manufacturers to assess product quality and consistency.Identify or develop appropriate in vitro and in vivo assays and models to predict in vivo human response to nanomaterials.
            Nonclinical Models
            Develop and evaluate in vitro and in vivo assays and models to assess safety and/or efficacy of nanomaterials in FDA-regulated products, in order to:
            Better understand the adequacy of preclinical evaluations necessary to assess safety and efficacy of nanomaterials;
                Obtain data on absorption, distribution, metabolism, and excretion, relevant to in vivo fate of nanomaterials; and
                Obtain data to improve understanding of structure-function relationships.Incorporate the relevant risk characterization information, hazard identification, exposure science, and risk modeling and methods into the safety evaluation of nanomaterials.
            Risk Characterization
            Targeted research in FDA-regulated product areas of potential nanotechnology applications where risk characterization information would help to enhance the understanding of hazard identification, exposure science, and risk modeling.Evaluate risk assessment approaches for risk management.
            Risk Assessment
            Enhance state of knowledge and scientific evidence to support potential development of generalized class-based approaches to risk assessment of FDA-regulated products containing nanomaterials.Integrate and standardize risk communication within the risk management framework
            Risk Communication
            Improve risk communication associated with FDA regulated product areas that either contain nanomaterials or product areas otherwise relevant to nanotechnology
**FDA Coordination**Coordination of FDA’s nanotechnology regulatory science research efforts, including CORES-funding and activities supported by other funding sources (see Figure 1 below).FDA's framework for nanotechnology regulatory science research efforts includes core laboratory facilities, staff training, and CORES (Collaborative Opportunities for Reseaarch Excellence in Science).
Figure 1: FDA Nanotechnology Regulatory Science Program
**FDA Nanotechnology Regulatory Science Research Plan—Implementation Strategy**
The Nanotechnology Regulatory Science Research Program encompasses all FDA nanotechnology regulatory science projects and related activities (e.g., reporting) and is implemented through program oversight and strategic partnerships.
**Program Oversight**
Ensure resources are used responsibly to address FDA’s nanotechnology regulatory science needs:
Use internal databases and other resources to track and manage resources and outcomes:
    CORES and Center-funded research projects will be tracked
        Specialized equipment for the conducting of nanotechnology-related projects will be available to staff
    Provide CORES funding for collaborative projects addressing identified priority needs in nanotechnology regulatory science through peer-reviewed processes:
    intramural competitive grants
        extramural competitive grants or contracts
    Perform periodic reviews of nanotechnology regulatory science research:
    Review of ongoing CORES and Center-funded projects for relevance to identified priority needs, scientific quality, and productivity
        Monitor progress of individual projects funded through the CORES program, as well as Center-funded regulatory science projects
        Identify gaps in portfolio, synergistic efforts, and new collaborators
        Periodically revisit stated nanotechnology research priorities and revise as needs and state-of-art change**Strategic Partnerships**
Leverage and use resources efficiently across the agency and with other government agencies, academia, and industry by facilitating collaborations within and external to FDA, as appropriate
Engage United States Government Agencies
    National Nanotechnology Initiative Member Agencies
    Engage in Domestic and International Collaborations
    Pursue additional collaborative efforts with outside FDA groups: academia, industry, international governments and organizations through Public-Private Partnerships as well as informal collaborations.**FDA Nanotechnology Regulatory Science Research Plan—Outcomes**
Posting the FDA Nanotechnology Regulatory Science Research Plan ensures transparency and public awareness of FDA’s activities and investment strategy in nanotechnology regulatory science.
The FDA Nanotechnology Regulatory Science Research Plan uses resources efficiently to address FDA’s nanotechnology regulatory science needs to support FDA readiness to evaluate products that incorporate or use nanotechnology.
Successful implementation of the FDA’s Nanotechnology Regulatory Science Program enhances or facilitates development and availability of safe, and as applicable, effective FDA-regulated products that contain or apply the science of nanotechnology.

                                                                                  Content current as of:
      03/19/2018Nanotechnology Programs at FDA

          
                        Nanotechnology Guidance Documents
          Nanotechnology Task Force
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop